Helius Medical Technologies, Inc. Class A (HSDT) Dividend History

Helius Medical Technologies, Inc. is a neurotech company focused on developing and commercializing non-invasive neuromodulation therapies to improve brain function and recovery. Their flagship product, the Portable Neuromodulation Stimulator (PoNS), aims to enhance neuroplasticity and aid in rehabilitation for patients with neurological conditions such as traumatic brain injury and stroke. The company emphasizes innovative solutions to address unmet needs in neurological healthcare.

642 Newtown Yardley Road, Newtown, PA, 18940
Phone: 215-944-6100
Website: https://www.heliusmedical.com

Dividend History

Helius Medical Technologies, Inc. Class A currently does not pay dividends

Company News

  • Helius Medical Technologies, Inc. announced the pricing of its public offering of 2,768,600 shares of Class A common stock and warrants to purchase up to 2,768,600 shares of common stock at a combined public offering price of $3.27 per share and accompanying warrants. The offering is expected to raise gross proceeds of $9.1 million.

    GlobeNewswire Inc.
  • Nevro (NVRO) delivered earnings and revenue surprises of 31.37% and 3.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
  • Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin. Bitdeer Technologies Group shares jumped 10.2% to $7.45 on Monday. Here are some other stocks moving in today's mid-day session. Gainers BitFuFu Inc. (NASDAQ: FUFU) shares jumped 107% to $13.20 amid volatility following the company's recent business combination with Arisz Acquisition Corp and listing on the Nasdaq. Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) climbed 89% to $5.31 after the company announced FDA clearance to recruit teen subjects into both of its ongoing Netherton Syndrome clinical studies. Renalytix Plc (NASDAQ: RNLX) gained 52.8% to $1.5890 after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company. Phunware, Inc. (NASDAQ: PHUN) climbed 42.7% to $10.11. Phunware is expected to report fourth-quarter results on March 12, 2024. Ainos, Inc. (NASDAQ: AIMD) gained 39.4% to $1.4650. Jaguar Health, Inc. (NASDAQ: JAGX) shares climbed 38.2% to $0.1223 after surging 50% on Friday. Cardiff Oncology, Inc. (NASDAQ: CRDF) rose 31.6% to $3.83 after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial. The E.W. Scripps Company (NASDAQ: SSP) gained 31.3% to $4.94. E.W. Scripps Director Charles L. Barmonde acquired a total of 10,500 shares an average price of $4.28. Helius Medical Technologies, Inc. (NASDAQ: HSDT) climbed 30% to $5.91. Helius Medical Technologies announced it secured HCPCS codes for portable neuromodulation stimulator mouthpiece and controller. Kineta, Inc. (NASDAQ: KA) gained 27% to $1.14. Kineta recently announced a restructuring and the exploration of strategic alternatives. BigBear.ai Holdings, Inc. (NYSE: BBAI) rose 25% to $4.3472. Critical Metals Corp. (NASDAQ: CRML) gained 24.4% to $12.44. Ocean Biomedical, Inc. (NASDAQ: OCEA) gained 22% to $2.44. Reliance Global Group, Inc. (NASDAQ: RELI) rose 21.7% to $0.6299 after gaining 11% on Friday. Akero Therapeutics, Inc. (NASDAQ: AKRO) ...

    Benzinga
  • Penny stocks under $1 to watch this week. The post Hot Penny Stocks To Buy For Under $0.99 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: AAPL AMC VTGN
Page data last updated 07/23/2025 13:02:45 UTC